申请人:KYORIN PHARMACEUTICAL CO., LTD
公开号:US20170066718A1
公开(公告)日:2017-03-09
Provided is a compound having a formyl peptide receptor like 1 (FPRL1) agonist effect.
The present invention relates to a compound represented by the general formula (I) or a pharmacologically acceptable salt thereof. The present invention also relates to a pharmaceutical composition containing the compound represented by the general formula (I) or a pharmacologically acceptable salt thereof.